PureTech Health PLC banner

Intrinsic Value

The intrinsic value of PureTech Health PLC (PTCHF) under the Base Case is 1.69 USD per share. Compared with the current market price of 1.64 USD, the stock appears Undervalued by 3% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

PTCHF Intrinsic Value
$1.69
Undervaluation 3%
Intrinsic Value
Price $1.64
Alert me when PTCHF is below its intrinsic value
Today $1.35 · 17.8% below the current price

PTCHF is cheaper than usual. It was this cheap or cheaper on just 13% of days in the past 5 years.

Alternatives to PTCHF

Fundamental Analysis

What PureTech Health Does

Biotechnology Health Care

PureTech Health is a biotechnology company that builds and develops new medicines for hard-to-treat diseases. It starts with scientific ideas around biology and turns them into drug programs, often by creating or backing separate portfolio companies to carry the work forward. Its value comes from discovering promising therapies, advancing them through research and clinical testing, and partnering or spinning them out when they reach the right stage.

Headquarters
United States of America US
Employees
61
IPO date
Jun 19, 2015
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
PureTech Health PLC

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one PTCHF stock?

The intrinsic value for PureTech Health PLC (PTCHF) under the Base Case is 1.69 USD.

Is PTCHF stock undervalued or overvalued?

Compared with the current market price of 1.64 USD, the stock appears Undervalued by 3% .

Back to Top